Ad
BPTH - Bio Path Holdings Stock Trading
About | Bio-Path Holdings Inc. (NASDAQ:BPTH)
Bio Path is engaged in the business of financing and commercializing novel cancer therapeutics acquired from MD Anderson Cancer Center. Currently in Phase human trial.
Quote | Bio-Path Holdings Inc. (NASDAQ:BPTH)
| Last: | $1.58 |
|---|---|
| Change Percent: | -0.61% |
| Open: | $1.66 |
| Close: | $1.58 |
| High: | $1.6699 |
| Low: | $1.58 |
| Volume: | 12,621 |
| Last Trade Date Time: | 06/09/2023 03:00:00 am |
News | Bio-Path Holdings Inc. (NASDAQ:BPTH)
-
Dallas, Texas--(Newsfile Corp. - June 2, 2023) - Bio-Path Holdings, Inc. (NASDAQ: BPTH): Stonegate Capital Partners updates coverage on Bio-Path Holdings, Inc. (NASDAQ: BPTH). The full report can be accessed by clicking on the following link: BPTH Q1 23 Report To view the full announcement, ...
-
2023-05-12 10:06:37 ET Bio-Path Holdings, Inc. (BPTH) Q1 2023 Earnings Conference Call May 12, 2023, 08:30 AM ET Company Participants Will O'Connor - Investor Relations, Stern IR Peter Nielsen - President and Chief Executive Officer Anthony Price - Senior Vice Pr...
Message Board Posts | Bio-Path Holdings Inc. (NASDAQ:BPTH)
| Subject | By | Source | When |
|---|---|---|---|
| znewcar1: ML1.27 YH2.28 back under Feb? $BPTH | znewcar1 | investorshangout | 01/27/2023 6:37:54 PM |
| znewcar1: ML3.55 LOD3.57 Don't think $3 will hold | znewcar1 | investorshangout | 09/16/2022 7:05:58 PM |
| whytestocks: $BPTH News Article - Bio-Path Holdings to Announce Second Quarter 2022 Financial Result | whytestocks | investorshangout | 08/09/2022 11:00:54 PM |
| Anyway, pps has been climbing slowly & steadily | cfoofme | investorshub | 07/09/2022 6:57:47 PM |
| Anyone here still holding BPTH? | cfoofme | investorshub | 07/08/2022 11:30:11 PM |
Bio-Path Holdings Inc. Company Name:
BPTH Stock Symbol:
NASDAQ Market:
Bio-Path Holdings Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
Ad
